Véronique Orian‐Rousseau

This study shows that CD44 deletion in pancreatic cancer-associated fibroblasts reduces tumor volume, alters their morphology and function, and enhances anti-tumor immune responses.

This study shows targeting CD44 on bone marrow-derived cells reduces pancreatic cancer metastasis by disrupting immunosuppressive niches in the liver.

This study shows that targeting CD44v6/MET signaling disrupts colorectal cancer cell plasticity by repressing Lgr5+ cell reappearance and affecting YAP/TAZ signaling.